ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms is a research paper published in Haematologica (2023). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA172408
NCI NIH HHS
Grant: R50 CA211404
National Institutes of Health
Grant: 7R01CA172408-07
Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies
Fields of Study
MeSH Terms
Sustainable Development Goals